Chromocell Therapeutics Corporation’s $6.6 Million Initial Public Offering

Sullivan & Worcester represented Chromocell Therapeutics Corporation, while Manatt, Phelps & Phillips represented A.G.P./ Alliance Global Partners in the transaction. Chromocell Therapeutics Corporation executed their $6.6...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here